Ackrell Capital, LLC
OrganizationRelationship Network
| Connected Entity | Relationship Type |
Strength
(mentions)
|
Documents | Actions |
|---|---|---|---|---|
|
person
FINRA / SIPC
|
Membership |
7
|
3 | |
|
organization
FINRA
|
Membership |
6
|
2 | |
|
organization
SIPC
|
Membership |
6
|
2 | |
|
organization
Wana Brands
|
Investment analysis |
5
|
1 | |
|
person
FINRA/SIPC
|
Membership |
5
|
1 | |
|
organization
VCC Brands
|
Investment analysis |
5
|
1 | |
|
organization
Uber
|
Investment analysis |
5
|
1 | |
|
organization
Vapexhale
|
Investment analysis |
5
|
1 | |
|
organization
SC Labs
|
Business associate |
1
|
1 |
HOUSE_OVERSIGHT_024788.jpg
This document is page 152 of a 'Cannabis Investment Report' dated December 2017, produced by Ackrell Capital. It features profiles for four companies in the cannabis industry: KIVA Confections, Korova, LeafLink, and Leafly, detailing their locations, websites, and business descriptions. The document bears the Bates stamp 'HOUSE_OVERSIGHT_024788', indicating it is part of a production to the House Oversight Committee.
HOUSE_OVERSIGHT_024787.jpg
This document is page 151 of a report titled 'Top 100 Private Cannabis Companies 2018' produced by Ackrell Capital. It profiles four companies: Humboldt Legends, Incense Specialties, Jetty Extracts, and Kikoko, providing their locations, websites, and brief business descriptions. The document bears a 'HOUSE_OVERSIGHT_024787' stamp, indicating it was part of a document production for a House Oversight Committee investigation.
HOUSE_OVERSIGHT_024786.jpg
Page 150 from a December 2017 Cannabis Investment Report by Ackrell Capital. The document profiles four companies in the cannabis industry: Harborside Health Center, Harvest, Headset, and HelloMD, detailing their locations, websites, and business models. The document bears a House Oversight Committee Bates stamp.
HOUSE_OVERSIGHT_024784.jpg
This document is page 148 of a Cannabis Investment Report produced by Ackrell Capital, LLC in December 2017. It provides business profiles for four companies: FunkSac, Garden State Dispensary, GFarmaLabs, and Gold Coast Extracts. The document bears a Bates stamp 'HOUSE_OVERSIGHT_024784', indicating it was part of a document production to the House Oversight Committee.
HOUSE_OVERSIGHT_024782.jpg
This document is page 146 of a 'Cannabis Investment Report' dated December 2017, produced by Ackrell Capital. It provides corporate profiles for four cannabis-related companies: Eaze Solutions, Eel River Organics, Elemental Wellness, and Euflora. The document bears the Bates stamp 'HOUSE_OVERSIGHT_024782', indicating it was part of a production to the House Oversight Committee, likely regarding financial investigations.
HOUSE_OVERSIGHT_024780.jpg
This document is page 144 of a 'Cannabis Investment Report' dated December 2017, produced by Ackrell Capital. It contains company profiles for four businesses in the cannabis industry: Confident Cannabis, Cultivation Technologies, Cura Cannabis Solutions, and CW Analytical. The document bears a House Oversight Bates stamp number 024780.
HOUSE_OVERSIGHT_024779.jpg
This document is page 143 from a 2018 Ackrell Capital report titled 'Top 100 Private Cannabis Companies.' It profiles four specific companies: CannaCraft, CannaKorp, Colorado Harvest Company, and Columbia Care, detailing their locations, websites, and business models. The document bears a 'HOUSE_OVERSIGHT_024779' Bates stamp, indicating it was collected as evidence during a House Oversight Committee investigation, likely related to financial probes.
HOUSE_OVERSIGHT_024778.jpg
This document is page 142 of a 'Cannabis Investment Report' dated December 2017, published by Ackrell Capital. It profiles four companies in the cannabis industry: Brewbudz, Bud and Bloom, Calyx Brands, and Cannabis Reports, providing their locations, websites, and brief business descriptions. The document bears the Bates stamp HOUSE_OVERSIGHT_024778, indicating it was part of a production to the House Oversight Committee, though no direct link to Epstein is visible on this specific page.
HOUSE_OVERSIGHT_024777.jpg
This document appears to be page 141 of a report titled 'Top 100 Private Cannabis Companies 2018' produced by Ackrell Capital. It lists profiles for four companies: Beboe, Berkeley Patients Group, BioTrackTHC, and Bloom Farms. The document bears a 'HOUSE_OVERSIGHT_024777' Bates stamp, indicating it was part of a production of documents to the House Oversight Committee, likely related to a broader financial investigation.
HOUSE_OVERSIGHT_024776.jpg
This document is page 140 of a 'Cannabis Investment Report' dated December 2017, produced by Ackrell Capital. It profiles four companies in the cannabis industry: Auntie Dolores, Baker Technologies, BAS Research, and BDS Analytics. The document bears a Bates stamp 'HOUSE_OVERSIGHT_024776', indicating it is part of a document production to the House Oversight Committee, likely related to financial investigations, though no direct mention of Jeffrey Epstein appears on this specific page.
HOUSE_OVERSIGHT_024775.jpg
This document is page 139 of an Ackrell Capital investment report titled 'Chapter VIII Top 100 Private Cannabis Companies 2018'. It provides company profiles for AEssenseGrows, Ample Organics, Apeks Supercritical, and The Apothecarium, detailing their locations, websites, and business descriptions. The document bears the Bates stamp HOUSE_OVERSIGHT_024775, indicating it was part of a document production to the House Oversight Committee.
HOUSE_OVERSIGHT_024774.jpg
This document is page 138 from a December 2017 Cannabis Investment Report produced by Ackrell Capital. It lists the 'Top 100 Private Cannabis Companies' for 2018, categorized alphabetically across four columns. The document bears a 'HOUSE_OVERSIGHT_024774' stamp, indicating it is part of a House Oversight Committee investigation file.
HOUSE_OVERSIGHT_024773.jpg
This document serves as the introduction to Chapter VIII of an Ackrell Capital report, presenting their 2018 list of the top 100 private cannabis companies. The text outlines the subjective selection criteria, highlights the financial risks and challenges faced by early-stage cannabis companies, and includes a disclaimer regarding potential conflicts of interest due to Ackrell Capital's investment activities.
HOUSE_OVERSIGHT_024770.jpg
This document is page 134 of a 'Cannabis Investment Report' dated December 2017, produced by Ackrell Capital, LLC. It contains data visualizations and tables detailing capital raised by private cannabis-related companies globally in 2016 and 2017, listing specific financings for companies like düber Technologies and Eaze Solutions. The document bears a 'HOUSE_OVERSIGHT_024770' Bates stamp, indicating it was part of a document production to the House Oversight Committee, likely related to investigations into financial institutions connected to Jeffrey Epstein, though Epstein himself is not mentioned on this specific page.
HOUSE_OVERSIGHT_024769.jpg
This document is a page from an Ackrell Capital report (Chapter VII) discussing private capital markets in the cannabis industry. It analyzes the sources of capital available to early-stage companies, notes the absence of traditional institutional investors due to legal issues, and references data from 2016 through November 2017. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production for a congressional investigation.
HOUSE_OVERSIGHT_024768.jpg
This document is page 132 of a December 2017 Cannabis Investment Report by Ackrell Capital, LLC. It provides a detailed comparison of Canadian stock markets (TSX, TSXV, and CSE) regarding their suitability for cannabis-related companies, listing requirements, and market values. The document bears a 'HOUSE_OVERSIGHT_024768' Bates stamp, indicating it was part of a document production to the House Oversight Committee, though no specific individuals (Epstein or otherwise) are named in the text of this specific page.
HOUSE_OVERSIGHT_024767.jpg
This document is page 131 of a report by Ackrell Capital titled 'Chapter VII Capital Markets for Cannabis Companies.' It presents a detailed financial table of companies listed on the Canadian Securities Exchange as of November 30, 2017. The table includes stock prices, market values, enterprise values, revenue, and EBITDA multiples for numerous cannabis-related entities. The document bears the Bates stamp 'HOUSE_OVERSIGHT_024767', indicating it was part of a production to the House Oversight Committee.
HOUSE_OVERSIGHT_024765.jpg
This document is page 129 of a financial report by Ackrell Capital, LLC, titled 'Chapter VII Capital Markets for Cannabis Companies'. It presents a bar chart and table analyzing capital raised by Canadian publicly traded cannabis companies for the Last Twelve Months (LTM) ended September 30, 2017, sourced from S&P Global Market Intelligence. While part of a House Oversight document dump (indicated by Bates stamp HOUSE_OVERSIGHT_024765), the page contains purely financial market metrics regarding the TSX, TSXV, and CSE exchanges and names no specific individuals.
HOUSE_OVERSIGHT_024764.jpg
This document is page 128 of a December 2017 Cannabis Investment Report by Ackrell Capital. It features a line graph tracking Canadian Cannabis Stock Price Performance against various indices from September 2016 to November 2017, highlighting market events such as the PM's legalization announcement and Constellation Brands' investment in Canopy Growth. The page bears the Bates stamp HOUSE_OVERSIGHT_024764, indicating it is part of a larger production of documents, likely related to congressional oversight, though no specific connection to Jeffrey Epstein or his associates is visible in the text of this specific page.
HOUSE_OVERSIGHT_024763.jpg
This document is page 127 of a report by Ackrell Capital titled 'Capital Markets for Cannabis Companies.' It provides a financial summary of Canadian publicly traded cannabis-related companies as of November 30, 2017, including market value and revenue data for companies on the TSX, TSXV, and CSE. The text also references the positive market impact of Prime Minister Justin Trudeau's legislative announcements and an investment by Constellation Brands into Canopy Growth. The document bears a 'HOUSE_OVERSIGHT' Bates stamp.
HOUSE_OVERSIGHT_024762.jpg
This document is page 126 from a December 2017 Cannabis Investment Report by Ackrell Capital. It features a detailed comparison table of U.S. stock markets (Nasdaq, NYSE, and OTC), analyzing them by tiers, listed companies, market value, and regulatory requirements. The document bears the Bates stamp 'HOUSE_OVERSIGHT_024762', indicating it was obtained during a House Oversight Committee investigation, likely related to financial records involving major banks or investment firms.
HOUSE_OVERSIGHT_024761.jpg
This document is Page 125 of a financial report produced by Ackrell Capital, LLC, titled 'Chapter VII Capital Markets for Cannabis Companies.' It contains a data table listing 'Over The Counter' cannabis stocks with market values greater than $25 million as of November 30, 2017. The table provides financial metrics such as stock price, market value, enterprise value, and revenue for numerous entities. The document bears the Bates stamp 'HOUSE_OVERSIGHT_024761', indicating it was part of a document production to the House Oversight Committee, likely related to investigations into financial records.
HOUSE_OVERSIGHT_024760.jpg
This document is page 124 of a 'Cannabis Investment Report' dated December 2017, produced by Ackrell Capital. It contains financial tables listing market data (stock price, market value, enterprise value, revenue, EBITDA) for various cannabis-related companies listed on Nasdaq, NYSE, and AMEX as of November 30, 2017. The document bears a 'HOUSE_OVERSIGHT_024760' stamp, indicating it is part of a larger production of documents to the House Oversight Committee.
HOUSE_OVERSIGHT_024759.jpg
This document is page 123 of a report by Ackrell Capital regarding capital markets for cannabis companies, bearing a House Oversight Bates stamp. It presents statistical data on capital raised by U.S. publicly traded cannabis companies for the twelve months ending September 30, 2017, breaking down amounts by exchange (Nasdaq, NYSE, OTC). While part of a document production likely related to broader financial investigations (possibly involving banks linked to Epstein), this specific page contains no direct references to Jeffrey Epstein or his associates.
HOUSE_OVERSIGHT_024758.jpg
This document is page 122 of a December 2017 Cannabis Investment Report by Ackrell Capital. It provides a financial summary and stock price performance analysis of U.S. publicly traded cannabis-related companies as of November 2017. The report notes that the election of Donald Trump and the confirmation of Jeff Sessions did not negatively impact the stock performance of these companies. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, suggesting it was part of a document production to Congress.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity